XmAb541

· Xencor, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XmAb541, covering 2026-03-17 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors [Phase 1]